Status:
COMPLETED
Quality Control and Evaluation in Standard COPD Management
Lead Sponsor:
Tongji Hospital
Collaborating Sponsors:
Affiliated hospital of Guilin medical university,China
University hospital of Hubei university for nationalities,China
Conditions:
COPD
Eligibility:
All Genders
18+ years
Brief Summary
There is lack of quality control and evaluation indexes for standard COPD management in hospitals in China, leading to nonstandard in COPD management and discrepancy in therapeutic efficiency. This st...
Eligibility Criteria
Inclusion
- Clinical manifestation of COPD; post bronchodilator FEV1/FVC\<0.70
Exclusion
- 1\. lung cancer. 2. Any history of psychiatric disorders. 3.HIV positive. 4.Breastfeeding, pregnancy or planning to be pregnant. 5.Estimated lifetime less than 1 years due to underlying diseases.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03314077
Start Date
November 1 2017
End Date
December 31 2019
Last Update
March 25 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
TongjiChibi hospital
Chibi, Hubei, China
2
Tongji hospital
Wuhan, Hubei, China